Patients With Type 2 Diabetes

March 24, 2026 updated by: National Taiwan University Hospital

Cohort Study of Patients With Type 2 Diabetes

Diabetes mellitus

Study Overview

Status

Recruiting

Conditions

Detailed Description

This study aims to establish both retrospective and prospective cohorts of patients with type 2 diabetes, enabling long-term follow-up of metabolic factors and related complications (such as cardiovascular disease, nephropathy, and neuropathy), as well as changes in nutritional status and physical function (including dietary habits, body composition, and grip strength). The goal is to identify risk factors that influence clinical outcomes and to provide evidence to support individualized treatment and integrated care strategies.

Study Type

Observational

Enrollment (Estimated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Taiwan
    • Zhongzheng Dist
      • Taipei, Zhongzheng Dist, Taiwan, 100229
        • Recruiting
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This study will recruit adult participants aged 18 years or older who have been diagnosed with type 2 diabetes mellitus (T2DM), as confirmed by medical history, diagnostic codes, or current use of hypoglycemic medications. Eligible participants must be willing to join the study and provide written informed consent. In addition, they should be able to complete the required baseline assessments, including anthropometric and functional measurements such as height, weight, waist circumference, handgrip strength, and body composition.

Description

Inclusion Criteria:

  1. Adults aged 18 or older.
  2. Patients diagnosed with type 2 diabetes (based on medical history, diagnostic code, or use of hypoglycemic medication).
  3. Participants are willing to participate in the study and have signed the consent form.
  4. Participants are able to complete basic assessments (e.g., height, weight, waist circumference, grip strength, body composition, etc.).

Exclusion Criteria:

  1. Individuals who cannot understand the study content.
  2. Individuals who cannot cooperate with relevant assessments.
  3. Other individuals who are clinically deemed unsuitable for participation by the project leader.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Cohort Study of Patients With Type 2 Diabetes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in nutritional status and physical function (including dietary habits, body composition, and grip strength)
Time Frame: Everytime after physician's appointment(Usually 3 months).
Everytime after physician's appointment(Usually 3 months).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taiwan University Hospital

Investigators

  • Study Chair: Chia-Wen Lu, Present Professor, Department of Family Medicine, National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2025

Primary Completion (Estimated)

August 21, 2028

Study Completion (Estimated)

August 21, 2028

Study Registration Dates

First Submitted

November 16, 2025

First Submitted That Met QC Criteria

November 20, 2025

First Posted (Actual)

November 24, 2025

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202507201RINE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus Type 2

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe